Jill Feldman, Co-Founder of EGFR Resisters and Lung Cancer Patient and Advocate, shared a post on X:
“Attention.
The U.S. Department of Defense, CDMRP FY25 topic areas for the Peer-Reviewed Cancer Research Program (PRCRP) will add the cancer programs (lung, kidney, and pancreatic) that did not receive a separate appropriation for FY25 to the PRCRP.
Below is the list of the 22+ disease areas that will fall under PRCRP. Here is the link to the news release, which has information about focus areas and award mechanisms.
It’s something, but not enough.”
